应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ALLO Allogene Therapeutics Inc.
未开盘 07-16 16:00:00 EDT
3.50
+0.52
+17.45%
盘后
3.60
+0.10
+2.88%
19:58 EDT
最高
3.67
最低
3.00
成交量
895.84万
今开
3.00
昨收
2.98
日振幅
22.48%
总市值
7.31亿
流通市值
5.46亿
总股本
2.09亿
成交额
3,094万
换手率
5.74%
流通股本
1.56亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Allogene Therapeutics, Inc.盘中异动 早盘急速上涨5.37%报3.14美元
自选股智能写手 · 07-16 21:30
Allogene Therapeutics, Inc.盘中异动 早盘急速上涨5.37%报3.14美元
Allogene Therapeutics, Inc.盘中异动 快速上涨5.22%报2.82美元
自选股智能写手 · 07-12
Allogene Therapeutics, Inc.盘中异动 快速上涨5.22%报2.82美元
Allogene Therapeutics, Inc.盘中异动 股价大涨5.86%报2.53美元
自选股智能写手 · 07-11
Allogene Therapeutics, Inc.盘中异动 股价大涨5.86%报2.53美元
Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.19%报2.23美元
自选股智能写手 · 07-08
Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.19%报2.23美元
Allogene Therapeutics, Inc.盘中异动 早盘快速下挫5.15%报2.21美元
自选股智能写手 · 07-02
Allogene Therapeutics, Inc.盘中异动 早盘快速下挫5.15%报2.21美元
Allogene Therapeutics, Inc.盘中异动 大幅上涨5.13%报2.46美元
自选股智能写手 · 06-28
Allogene Therapeutics, Inc.盘中异动 大幅上涨5.13%报2.46美元
Allogene Therapeutics, Inc.盘中异动 早盘急速下挫5.00%报2.28美元
自选股智能写手 · 06-26
Allogene Therapeutics, Inc.盘中异动 早盘急速下挫5.00%报2.28美元
Allogene Therapeutics, Inc.盘中异动 快速下挫5.17%报2.48美元
自选股智能写手 · 06-25
Allogene Therapeutics, Inc.盘中异动 快速下挫5.17%报2.48美元
Allogene Therapeutics, Inc.盘中异动 股价大涨5.12%
自选股智能写手 · 06-22
Allogene Therapeutics, Inc.盘中异动 股价大涨5.12%
Allogene Therapeutics, Inc.盘中异动 早盘大幅上涨5.16%
自选股智能写手 · 06-20
Allogene Therapeutics, Inc.盘中异动 早盘大幅上涨5.16%
Allogene Therapeutics, Inc.盘中异动 下午盘快速跳水5.22%
自选股智能写手 · 06-19
Allogene Therapeutics, Inc.盘中异动 下午盘快速跳水5.22%
Allogene Therapeutics, Inc.盘中异动 股价大跌5.31%报2.41美元
自选股智能写手 · 06-14
Allogene Therapeutics, Inc.盘中异动 股价大跌5.31%报2.41美元
Allogene Therapeutics, Inc.盘中异动 股价大涨5.10%报2.68美元
自选股智能写手 · 06-12
Allogene Therapeutics, Inc.盘中异动 股价大涨5.10%报2.68美元
Allogene Therapeutics, Inc.盘中异动 股价大涨5.17%
自选股智能写手 · 06-11
Allogene Therapeutics, Inc.盘中异动 股价大涨5.17%
Allogene Therapeutics, Inc.盘中异动 下午盘股价大跌5.18%报2.38美元
自选股智能写手 · 06-05
Allogene Therapeutics, Inc.盘中异动 下午盘股价大跌5.18%报2.38美元
Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.20%报2.63美元
自选股智能写手 · 06-03
Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.20%报2.63美元
Allogene Therapeutics, Inc.盘中异动 下午盘股价大涨5.04%
自选股智能写手 · 05-31
Allogene Therapeutics, Inc.盘中异动 下午盘股价大涨5.04%
Allogene Therapeutics, Inc.2024财年第一财季实现净利润-65.00百万美元,同比增加34.14%
自选股智能写手 · 05-19
Allogene Therapeutics, Inc.2024财年第一财季实现净利润-65.00百万美元,同比增加34.14%
Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.00%
自选股智能写手 · 05-13
Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.00%
Allogene Therapeutics, Inc.盘中异动 快速下跌5.15%
自选股智能写手 · 05-09
Allogene Therapeutics, Inc.盘中异动 快速下跌5.15%
加载更多
公司概况
公司名称:
Allogene Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Allogene Therapeutics, Inc.于2017年11月30日在特拉华州成立,总部位于加利福尼亚州南旧金山。该公司是一家临床阶段免疫肿瘤学公司,开创了用于治疗癌症的基因工程异体T细胞疗法的开发和商业化。公司正在开发一种现成的T细胞候选产品系列,旨在靶向和杀死癌细胞。Allogene Therapeutics, Inc.工程改造的T细胞是同种异体的,这意味着它们来自健康供体,用于任何患者,而不是来自患者的个体患者,如自体T细胞的情况。
发行价格:
--
{"stockData":{"symbol":"ALLO","market":"US","secType":"STK","nameCN":"Allogene Therapeutics Inc.","latestPrice":3.5,"timestamp":1721160000000,"preClose":2.98,"halted":0,"volume":8958367,"hourTrading":{"tag":"盘后","latestPrice":3.6008,"preClose":3.5,"latestTime":"19:58 EDT","volume":41122,"amount":143828.2166,"timestamp":1721174304645},"delay":0,"floatShares":156000000,"shares":208784414,"eps":-1.792431,"marketStatus":"未开盘","marketStatusCode":0,"change":0.52,"latestTime":"07-16 16:00:00 EDT","open":3,"high":3.67,"low":3,"amount":30942742.4950402,"amplitude":0.224832,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.792431,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721203200000},"adr":0,"listingDate":1539230400000,"adjPreClose":2.98,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.99,"preClose":2.98,"latestTime":"09:08 EDT","volume":411,"amount":1185.4850298,"timestamp":1721135293055},"postHourTrading":{"tag":"盘后","latestPrice":3.6008,"preClose":3.5,"latestTime":"19:58 EDT","volume":41122,"amount":143828.2166,"timestamp":1721174304645},"volumeRatio":3.511173,"impliedVol":2.0054,"impliedVolPercentile":0.9286},"requestUrl":"/m/hq/s/ALLO","defaultTab":"news","newsList":[{"id":"2451614990","title":"Allogene Therapeutics, Inc.盘中异动 早盘急速上涨5.37%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451614990","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451614990?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:30","pubTimestamp":1721136650,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时30分,Allogene Therapeutics, Inc.股票出现异动,股价急速上涨5.37%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.20%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716213050af9298eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716213050af9298eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LENZ","BK4139","ALLO"],"gpt_icon":0},{"id":"2450495539","title":"Allogene Therapeutics, Inc.盘中异动 快速上涨5.22%报2.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450495539","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450495539?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:16","pubTimestamp":1720793785,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时16分,Allogene Therapeutics, Inc.股票出现异动,股价大幅上涨5.22%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.46%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712221625aef97c37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712221625aef97c37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","ALLO","BK4139"],"gpt_icon":0},{"id":"2450368008","title":"Allogene Therapeutics, Inc.盘中异动 股价大涨5.86%报2.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450368008","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450368008?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:30","pubTimestamp":1720704625,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时30分,Allogene Therapeutics, Inc.股票出现波动,股价大幅上涨5.86%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.43%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213025941f6408&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213025941f6408&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LENZ","ALLO"],"gpt_icon":0},{"id":"2449706649","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.19%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449706649","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449706649?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:05","pubTimestamp":1720447536,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时05分,Allogene Therapeutics, Inc.股票出现波动,股价快速拉升5.19%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.67%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708220536af911787&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708220536af911787&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LENZ","ALLO"],"gpt_icon":0},{"id":"2448725168","title":"Allogene Therapeutics, Inc.盘中异动 早盘快速下挫5.15%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448725168","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448725168?lang=zh_cn&edition=full","pubTime":"2024-07-02 22:48","pubTimestamp":1719931734,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日22时48分,Allogene Therapeutics, Inc.股票出现异动,股价大幅下跌5.15%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.77%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702224855941f3275&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702224855941f3275&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LENZ","ALLO","BK4139"],"gpt_icon":0},{"id":"2446561054","title":"Allogene Therapeutics, Inc.盘中异动 大幅上涨5.13%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446561054","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446561054?lang=zh_cn&edition=full","pubTime":"2024-06-28 02:47","pubTimestamp":1719514029,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日02时47分,Allogene Therapeutics, Inc.股票出现波动,股价急速拉升5.13%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.55%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628024709aef6f497&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628024709aef6f497&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LENZ","ALLO","BK4139"],"gpt_icon":0},{"id":"2446239903","title":"Allogene Therapeutics, Inc.盘中异动 早盘急速下挫5.00%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446239903","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446239903?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:07","pubTimestamp":1719410861,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时07分,Allogene Therapeutics, Inc.股票出现波动,股价快速跳水5.00%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.16%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626220741941f16a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626220741941f16a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LENZ","ALLO"],"gpt_icon":0},{"id":"2446844219","title":"Allogene Therapeutics, Inc.盘中异动 快速下挫5.17%报2.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446844219","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446844219?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:47","pubTimestamp":1719323278,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时47分,Allogene Therapeutics, Inc.股票出现波动,股价快速下挫5.17%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.18%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625214758af8f20ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625214758af8f20ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","ALLO","BK4139","LENZ"],"gpt_icon":0},{"id":"2445794755","title":"Allogene Therapeutics, Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445794755","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445794755?lang=zh_cn&edition=full","pubTime":"2024-06-22 04:00","pubTimestamp":1719000013,"startTime":"0","endTime":"0","summary":"北京时间2024年06月22日04时00分,Allogene Therapeutics, Inc.股票出现异动,股价急速上涨5.12%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622040013aef6106d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622040013aef6106d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LENZ","ALLO"],"gpt_icon":0},{"id":"2444248542","title":"Allogene Therapeutics, Inc.盘中异动 早盘大幅上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444248542","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444248542?lang=zh_cn&edition=full","pubTime":"2024-06-20 22:01","pubTimestamp":1718892114,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日22时01分,Allogene Therapeutics, Inc.股票出现异动,股价快速拉升5.16%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。消息层面,截至22时01分,《派杰投资维持Allogene Therapeutics买入评级,维持目标价11美元》资讯为影响Allogene Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620220154aef5db35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620220154aef5db35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALLO","BK4505"],"gpt_icon":0},{"id":"2444499456","title":"Allogene Therapeutics, Inc.盘中异动 下午盘快速跳水5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444499456","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444499456?lang=zh_cn&edition=full","pubTime":"2024-06-19 01:29","pubTimestamp":1718731799,"startTime":"0","endTime":"0","summary":"北京时间2024年06月19日01时29分,Allogene Therapeutics, Inc.股票出现异动,股价急速下挫5.22%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。消息层面,截至01时29分,《派杰投资维持Allogene Therapeutics买入评级,维持目标价11美元》资讯为影响Allogene Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619012959941ef45c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619012959941ef45c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLO","BK4505","BK4139","LENZ"],"gpt_icon":0},{"id":"2443367269","title":"Allogene Therapeutics, Inc.盘中异动 股价大跌5.31%报2.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443367269","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443367269?lang=zh_cn&edition=full","pubTime":"2024-06-14 23:43","pubTimestamp":1718379828,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日23时43分,Allogene Therapeutics, Inc.股票出现波动,股价快速下挫5.31%。截至发稿,该股报2.41美元/股,成交量53.2566万股,换手率0.26%,振幅3.94%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061423434896814595&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061423434896814595&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLO","LENZ","BK4505"],"gpt_icon":0},{"id":"2442544695","title":"Allogene Therapeutics, Inc.盘中异动 股价大涨5.10%报2.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442544695","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442544695?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:31","pubTimestamp":1718199091,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时31分,Allogene Therapeutics, Inc.股票出现波动,股价急速上涨5.10%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.34%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213131af8d2f8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213131af8d2f8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","ALLO","BK4139"],"gpt_icon":0},{"id":"2442873428","title":"Allogene Therapeutics, Inc.盘中异动 股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442873428","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442873428?lang=zh_cn&edition=full","pubTime":"2024-06-11 03:37","pubTimestamp":1718048241,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日03时37分,Allogene Therapeutics, Inc.股票出现异动,股价快速上涨5.17%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.33%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611033721af8cc72c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611033721af8cc72c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALLO","BK4139","BK4505"],"gpt_icon":0},{"id":"2441555202","title":"Allogene Therapeutics, Inc.盘中异动 下午盘股价大跌5.18%报2.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441555202","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441555202?lang=zh_cn&edition=full","pubTime":"2024-06-05 01:21","pubTimestamp":1717521693,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日01时21分,Allogene Therapeutics, Inc.股票出现异动,股价急速下跌5.18%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.00%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605012133941ec50a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605012133941ec50a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLO","BK4505","BK4139","LENZ"],"gpt_icon":0},{"id":"2440707495","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.20%报2.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440707495","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440707495?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:36","pubTimestamp":1717421784,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时36分,Allogene Therapeutics, Inc.股票出现异动,股价大幅上涨5.20%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.24%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。该信息摘要如下:Allogene Therapeutics Inc:5月24日Overland Pharmicals、Allogene Overland Biopharm公司签订了股票交换协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213625af8ba6f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213625af8ba6f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALLO","BK4505"],"gpt_icon":0},{"id":"2439784216","title":"Allogene Therapeutics, Inc.盘中异动 下午盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439784216","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439784216?lang=zh_cn&edition=full","pubTime":"2024-05-31 01:16","pubTimestamp":1717089365,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日01时16分,Allogene Therapeutics, Inc.股票出现波动,股价大幅上涨5.04%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024053101160596810e05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024053101160596810e05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALLO","BK4505"],"gpt_icon":0},{"id":"2436538181","title":"Allogene Therapeutics, Inc.2024财年第一财季实现净利润-65.00百万美元,同比增加34.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436538181","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436538181?lang=zh_cn&edition=full","pubTime":"2024-05-19 00:25","pubTimestamp":1716049528,"startTime":"0","endTime":"0","summary":"3月31日,Allogene Therapeutics, Inc.公布财报,公告显示公司2024财年第一财季净利润为-65.00百万美元,同比增加34.14%;其中营业收入为22000.00美元,同比减少57.69%,每股基本收益为-0.38美元。从资产负债表来看,Allogene Therapeutics, Inc.总负债1.25亿美元,其中短期债务6.93百万美元,资产负债比为4.69,流动比率为0.13。机构评级:截至2024年3月31日,当前有12家机构对Allogene Therapeutics, Inc.目标价做出预测,其中目标均价为11.59美元,其中最低目标价为4.50美元,最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051900253287781109&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051900253287781109&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLO","LENZ"],"gpt_icon":0},{"id":"2435375753","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435375753","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435375753?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:04","pubTimestamp":1715609052,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时04分,Allogene Therapeutics, Inc.股票出现异动,股价急速上涨5.00%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.24%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513220412861ecd3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513220412861ecd3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","ALLO","BK4139","LENZ"],"gpt_icon":0},{"id":"2434779662","title":"Allogene Therapeutics, Inc.盘中异动 快速下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434779662","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434779662?lang=zh_cn&edition=full","pubTime":"2024-05-09 00:52","pubTimestamp":1715187127,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日00时52分,Allogene Therapeutics, Inc.股票出现异动,股价快速跳水5.15%。Allogene Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.12%。Allogene Therapeutics, Inc.公司简介:Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司,专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050900520787e867df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050900520787e867df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","ALLO","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.allogene.com","stockEarnings":[{"period":"1week","weight":0.5217},{"period":"1month","weight":0.4894},{"period":"3month","weight":-0.0028},{"period":"6month","weight":0.0937},{"period":"1year","weight":-0.3384},{"period":"ytd","weight":0.0903}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1285},{"period":"6month","weight":0.1855},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.1884}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Allogene Therapeutics, Inc.于2017年11月30日在特拉华州成立,总部位于加利福尼亚州南旧金山。该公司是一家临床阶段免疫肿瘤学公司,开创了用于治疗癌症的基因工程异体T细胞疗法的开发和商业化。公司正在开发一种现成的T细胞候选产品系列,旨在靶向和杀死癌细胞。Allogene Therapeutics, Inc.工程改造的T细胞是同种异体的,这意味着它们来自健康供体,用于任何患者,而不是来自患者的个体患者,如自体T细胞的情况。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.071404},{"month":2,"riseRate":0.666667,"avgChangeRate":0.050796},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.111126},{"month":4,"riseRate":0.5,"avgChangeRate":0.005289},{"month":5,"riseRate":0.166667,"avgChangeRate":0.032626},{"month":6,"riseRate":0.5,"avgChangeRate":0.040631},{"month":7,"riseRate":0.5,"avgChangeRate":0.081885},{"month":8,"riseRate":0.4,"avgChangeRate":-0.044471},{"month":9,"riseRate":0.6,"avgChangeRate":-0.052215},{"month":10,"riseRate":0.2,"avgChangeRate":-0.105941},{"month":11,"riseRate":0.333333,"avgChangeRate":0.009962},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.098907}],"exchange":"NASDAQ","name":"Allogene Therapeutics Inc.","nameEN":"Allogene Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.0","shortVersion":"4.25.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Allogene Therapeutics Inc.(ALLO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Allogene Therapeutics Inc.(ALLO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Allogene Therapeutics Inc.,ALLO,Allogene Therapeutics Inc.股票,Allogene Therapeutics Inc.股票老虎,Allogene Therapeutics Inc.股票老虎国际,Allogene Therapeutics Inc.行情,Allogene Therapeutics Inc.股票行情,Allogene Therapeutics Inc.股价,Allogene Therapeutics Inc.股市,Allogene Therapeutics Inc.股票价格,Allogene Therapeutics Inc.股票交易,Allogene Therapeutics Inc.股票购买,Allogene Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Allogene Therapeutics Inc.(ALLO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Allogene Therapeutics Inc.(ALLO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}